Long-Term Efficacy and Safety of Odronextamab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Pooled Analysis from the ELM-1 and ELM-2 StudiesJohn N. Allan,Jennifer L. Crombie,Matthew Matasar,Max S. Topp,Jan Walewski,Tae Min Kim,Won-Seog Kim, Yuan Cheng,Dina Flink, Bertha Fearon Chalet,Hesham Mohamed,Srikanth Ambati,Aafia Chaudhry,Jon E. ArnasonBlood（2024）引用 0|浏览3AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
